"Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers"

If you are interested in learning more about this trial, ResearchMatch can help by contacting the trial team for you. If you’re not a volunteer yet, you’ll first need to join ResearchMatch before we can share your contact information with the research team.